CHIMERA-DDR: A Machine Learning Framework for Classifying Heterogeneous Mismatch-Repair and Homologous-Recombination Deficiency Patterns in Prostate Cancer. (Sharma K, Wilson DA, Wang Y, Haider S, Bhatlapenumarthi V, Boiarsky D, Cipriaso JM, Yermakov L, Dutta R, Vashisth M, Coleman IM, Bankhead A, Jadhav SK, Neupane B, Taylor BW, Morrissey C, Schweitzer MT, Montgomery RB, Rao S, Nevalainen MT, Nelson AA, Antonarakis ES, Pilié PG, Berchuk JE, Zarrabi KK, Pritchard CC, Kthari A, Chen HZ, George B, Kurzrock R, Ha G, Nelson PS, Auer PL, Banerjee A, Kilari D, De Sarkar N) bioRxiv 2025 Oct 14 PMID: 41278905 PMCID: PMC12633065 11/24/2025
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy. (Mountzios G, Sun L, Cho BC, Demirci U, Baka S, Gümüş M, Lugini A, Zhu B, Yu Y, Korantzis I, Han JY, Ciuleanu TE, Ahn MJ, Rocha P, Mazières J, Lau SCM, Schuler M, Blackhall F, Yoshida T, Owonikoko TK, Paz-Ares L, Jiang T, Hamidi A, Gauto D, Recondo G, Rudin CM, DeLLphi-304 Investigators) N Engl J Med 2025 Jul 24;393(4):349-361 PMID: 40454646 SCOPUS ID: 2-s2.0-105012375634 06/02/2025 99 Citations
Cancer treatment paradigms in the precision medicine era. (Subbiah V, Curigliano G, Sicklick JK, Kato S, Tasken K, Medford A, Rieke DT, Chen HZ, Wahida A, Buschhorn L, Horgan D, Kurzrock R) Nat Med 2025 Nov;31(11):3609-3611 PMID: 40394190 SCOPUS ID: 2-s2.0-105005797459 05/21/2025 7 Citations